DCP Capital is a Greater China focused private equity firm.
Business Model: B2B
Revenue: $0
Employees: 0-0
Address: 157 Columbus Avenue
City: New York
State: NY
Zip: 10023
Country: US
DCP Capital is an international private equity firm that focuses on opportunities in Asia. The DCP team previously led KKR and Morgan Stanley’s private equity businesses in Greater China, with an outstanding long-term track record across multiple economic cycles
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2021 | Simple Love | Series B | 0 |
3/2022 | Simple Love | Series C | - |
11/2021 | Datong | Private Equity Round | 234.8M |
5/2018 | Venus MedTech | Private Equity Round | - |
12/2021 | Adopt A Cow | Series B | - |
2/2021 | Xingsheng Youxuan | Series D | 0 |
4/2021 | Adopt A Cow | Private Equity Round | - |
9/2020 | Tonghua Dongbao Pharmaceutical | Post-IPO Equity | 283M |
5/2021 | Valgen Medtech | Series B | 188M |
11/2019 | Far East Horizon | Post-IPO Equity | - |
10/2020 | Yuanfudao | Series G | 0 |
10/2020 | Broncus Technologies | Series C | - |
2/2021 | Fenbi | Series A | 390M |
3/2022 | Simple Love | Series C | - |
12/2021 | Adopt A Cow | Series B | - |
11/2021 | Datong | Private Equity Round | 0 |
5/2021 | Valgen Medtech | Series B | 0 |
4/2021 | Adopt A Cow | Private Equity Round | - |
3/2021 | Simple Love | Series B | 0 |
2/2021 | Xingsheng Youxuan | Series D | 0 |
2/2021 | Fenbi | Series A | 0 |
10/2020 | Yuanfudao | Series G | 0 |
10/2020 | Broncus Technologies | Series C | - |
Name | Price |
---|
Name | Size | Announced Date |
---|